-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

101. Red Cells and Erythropoiesis, Excluding Iron: Poster III

Symposia: Red Cells and Erythropoiesis, Excluding Iron Program: Oral and Poster Abstracts
Type: Poster
Monday, December 12, 2022: 6:00 PM-8:00 PM
Hall D (Ernest N. Morial Convention Center)

Emmanuel Olivier, PhD1*, Zi Yan2* and Eric E. Bouhassira, PhD1

1Department of Cell Biology, Albert Einstein College of Medicine, Bronx, NY
2Dept. of Cell Biology, Albert Einstein College of Medicine, Bronx, NY

Jayme L. Olsen, PhD1, Kathleen E. McGrath, PhD2, Kristin Murphy, PhD2*, Taylor Schofield2*, Michael Getman, MS2*, Mohandas Narla, DSc3, Lionel Blanc, PhD4, Vincent P Schulz, PhD5*, Patrick G. Gallagher, MD6, Laurie A. Steiner, MD2 and James Palis, MD2

1Department of Biomedical Genetics, University of Rochester, Rochester, NY
2Department of Pediatrics, University of Rochester, Rochester, NY
3New York Blood Center, New York, NY
4The Feinstein Institutes for Medical Research, Manhasset, NY
5Department of Pediatrics, Yale University School of Medicine, New Haven, CT
6Pediatrics, Pathology, Genetics, Yale School of Medicine, Hamden, CT

Min Wu, PhD1, Kathryn Wang, PhD2* and Brian MacDonald, MBChB, PhD2*

1DISC Medicine, Cambridge, MA
2Disc Medicine, Watertown, MA

Greggory Myers1*, Lei Yu2*, Ginette Balbin-Cuesta, MD, PhD3,4, Ayse Bilge Ozel, PhD5*, James Douglas Engel1* and Rami Khoriaty, MD1,6,7,8

1Department of Cell and Developmental Biology, University of Michigan, Ann Arbor, MI
2Department of Internal Medicine, University of Michigan, Ann Arbor, MI
3Cellular and Molecular Biology Program, University of Michigan, Ann Arbor, MI
4Medical Scientist Training Program, University of Michigan, Ann Arbor, MI
5Department of Human Genetics, University of Michigan, Ann Arbor, MI
6Program in Cellular and Molecular Biology, University of Michigan, Ann Arbor, MI
7Rogel Cancer Center, University of Michigan, Ann Arbor, MI
8Department of Internal Medicine, Division of Hematology/Oncology, University of Michigan, Ann Arbor, MI

Valéna Karaghiannis1,2*, Darko Maric3,4*, Céline Garrec5*, Nada Maaziz6*, Alexandre Buffet7*, Vincent Antunes8*, Amandine le Roy9*, Fabrice Airaud10*, Bernard Aral11*, Loic Schmitt12*, Sébastien Corbineau9*, Lamisse Mansour-Hendili13*, Valentine Lesieur9*, Antoine Rimbert14*, Fabien Laporte15*, Marine Delamare16*, Stephane Bezieau5*, Bruno Cassinat, PharmD, PhD17, Frédéric Galactéros, MD, PhD18*, Anne-Paule Gimenez-Roqueplo19*, Nelly Burnichon20*, Holger Cario, MD, PhD21, Richard van Wijk22*, Celeste Bento, MSc23*, Anaise Blouet, MD24*, Juliette Bouteloup, MD25*, Françoise Boyer perrard26*, Aisha Aiko Bruce, MD27, Emilie Cayssials, MD28*, Nicole Casadevall, MD29, Brieuc Cherel30*, Marielaure Couec, MD15*, Louis Drevon, MD31*, Cecile Dumesnil, MD32*, Thierry Lamy De La Chapelle, MD, PhD33*, Marion Gambart, MD34*, Loic Garcon, MD PhD35*, Brigitte Granel36*, Pierre Hirsch, MD-PhD37*, Agnès Lahary38*, Amira Mejri39*, Sandrine Meunier, MD40*, Franck E. Nicolini, MD, PhD41, Emmanuel Raffoux42*, Dana Ranta, MD43*, Nicolas Schleinitz44*, Jean Baptiste Valentin, MD45*, Mathieu Wemeau, MD46*, Francois Girodon, MD, PhD 47, David Hoogewijs48*, Betty Gardie, PhD49* and Olivier Hermine, MD, PhD50,51,52

1Ecole Pratique des Hautes Etudes, EPHE, Université Paris Sciences et Lettres, France, Paris, France
2Université de Nantes, CNRS, INSERM, l’institut du thorax, F-44000 Nantes, Nantes, France
3Section of Medicine, Department of Endocrinology, Metabolism and Cardiovascular System, University of Fribourg, CH-1700 Fribourg, Switzerland, Fribourg, Switzerland
4National Center of Competence in Research “Kidney.CH”, Switzerland, Fribourg, Switzerland
5Centre Hospitalier Universitaire De Nantes, Nantes, FRA
6Service d’Hématologie Biologique, Pôle Biologie, CHU de Dijon, Dijon, France, Dijon, France
7INSERM, UMR970, Paris-Centre De Recherche Cardiovasculaire, Paris, FRA
8ch, zurich, France
92 Université de Nantes, CNRS, INSERM, l’institut du thorax, F-44000 Nantes, France, nantes, France
10CHU De NANTES, NANTES, FRA
11Chu Dijon Bourgogne, Dijon, France
12Ch rennes, rennes, France
13APHP, Paris, France
14Chu NAntes, nantes, France
15Chu Nantes, Nantes, France
16Chu nantes, Nantes, France
17INSERM UMR 1131, Institut de Recherche Saint-Louis, Paris, France
18Unité des Maladies Génétiques du Globule Rouge, CHU Henri Mondor, Créteil, France
19Assistance Publique Hôpitaux De Paris, Paris, FRA
20INSERM U970, Paris, FRA
21Department of Pediatrics and Adolescent Medicine, University Medical Center Ulm, Ulm, Germany
22Central Diagnostic Laboratory - Research, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands
23Hospital Pediatrico De Coimbra, Coimbra, Coimbra, PRT
24Service oncologie-hématologie, Centre Hospitalier, Cholet, Cholet, France
25Hematology Department, Chalon Center Hospital, Chalon-sur-Saone, France
26Ch Angers, Angers, France
27University of Alberta, Edmonton, AB, Canada
28Poitiers University Hospital, Poitiers, France
29AP-HP, Laboratoire d’hématologie biologique, Hôpital Saint-Antoine, Paris, France, Paris, France
30Chu Rennes, rennes, France
31ApHP, paris, France
32Pediatric Oncology and Hematology Unit, Charles Nicolle Rouen University Hospital, Rouen, France
33Clinical hematology, University Hospital of Rennes, Rennes, France
34CHU de Toulouse, Toulouse, France
35Laboratoire d'Hématologie, CHU Amiens, Amiens, France
36Ch marseille, marseille, France
37Université Pierre et Marie Curie, Paris, France
38ch rouens, rouens, France
39Service hématologie clinique -GHRMSA Ch Mulhouse, Mulhouse, France
40Chu Lyon, Lyon Cedex, FRA
41Centre Hospitalier Lyon Sud, LYON Cedex 03, France
42Department of Hematology, Université de Paris, Saint-Louis Hospital, Paris, France
43Centre Hospitalier Universitaire, Nancy, France
44Service De Medecine Interne, CHU Conception, AP-HM, Marseille, FRA
45Chu Tours, Chambray Les Tours, FRA
46CHRU Lille, Paris, FRA
47Laboratorie D'Hematologie CHU Dijon, Dijon, France
48University of ZüRich, ZüRich, CHE
49Université de Nantes, CNRS, INSERM, l’institut du thorax, F-44000 Nantes, France, Nantes, FRA
50INSERM U1163 and CNRS 8254, Imagine Institute, Université Sorbonne Paris Cité, Paris, France
51Laboratory of Excellence GR-Ex, Paris, France
52Necker–Enfants Malades Hospital and Imagine Institute, CEREMAST, Paris, France

Hanny Al-Samkari, MD1, Rachael F. Grace, MD2, Eduard J. van Beers, MD, PhD3*, Feng Tai, PhD4*, Jaime Morales-Arias, MD4*, Vanessa Beynon, MD4* and Andreas Glenthøj, MD, PhD5

1Division of Hematology Oncology, Massachusetts General Hospital, Cambridge, MA
2Dana-Farber/Boston Children’s Cancer and Blood Disorders Center, Harvard Medical School, Boston, MA
3Benign Hematology Center, Van Creveldkliniek, University Medical Center Utrecht, University of Utrecht, Utrecht, Netherlands
4Agios Pharmaceuticals, Inc., Cambridge, MA
5Department of Hematology, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark

Amit Choudhury, PhD1*, Wim Noël, PhD2*, Tarek Ebrahim, MD3*, Cathye Shu, PhD4*, Leona E Ling, PhD5* and Bruno Fattizzo, MD6*

1Janssen Research & Development, LLC, Cambridge, PA
2Janssen Scientific Affairs, LLC, Immunology, Brussels, Belgium
3Janssen Pharmaceutical Companies of Johnson & Johnson, Cambridge, MA
4Janssen Research & Development, LLC, Spring House, PA
5Janssen Research & Development, LLC, Cambridge, MA
6Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico and University of Milan, Milan, Italy

Daniel Kuppers, PhD1*, Yong Peng, PhD2*, Sonali Arora, MS3*, Cindy Wladyka, BS3*, Anne Wilhite3*, Derek Stirewalt3, Beverly Torok-Storb, PhD4*, Andrew Hsieh, MD3*, Chuan He, PhD5,6,7* and Patrick Paddison, PhD8*

1Human Biology Division, Fred Hutchinson Cancer Center, Seattle
2The University of Chicago, Chicago
3Fred Hutchinson Cancer Center, Seattle
4FHCRC D1-100, Seattle, WA
5Department of Biochemistry and Molecular Biology, University of Chicago, Chicago, IL
6Howard Hughes Medical Institute, University of Chicago, Chicago, IL
7Department of Chemistry and Institute for Biophysical Dynamics, University of Chicago, Chicago, IL
8Human Biology Division, Fred Hutchinson Cancer Center, Seattle, WA

Seong Juyong1,2*, Dong-Yeop Shin, MD, PhD3*, Ja Min Byun, MD, PhD4, Youngil Koh, MD, PhD3, Junshik Hong, MD5, Inho Kim, MD, PhD6* and Sung-Soo Yoon, MD, PhD7

1Hematology, Seoul national univerity hospital, Seoul, Korea, Republic of (South)
2Seoul national university hospital, Seoul, South Korea
3Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea, Republic of (South)
4Seoul National University, Seoul, Korea, Republic of (South)
5Department of Internal Medicine, Gachon University Gil Hospital, Seoul, Korea, Republic of (South)
6Internal Medicine, Seoul National University Hospital, Seoul, Korea, Republic of (South)
7Division of Hematology/Medical Oncology, Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea, Republic of (South)

Tomasz M. Grzywa, PhD1,2*, Magdalena Justyniarska1*, Anna Sosnowska, PhD1*, Patrycja Szpak, MSc.3*, Karol Czubak4*, Klaudyna Fidyt, MSc1*, Ilona Kalaszczynska, PhD3*, Milena Małecka-Giełdowska, MSc5*, Olga Ciepiela, PhD5*, Agnieszka Tomaszewska, MD, PhD6*, Grzegorz W Basak, MD, PhD7*, Jakub Golab, MD, PhD1* and Dominika Nowis, MD, PhD2*

1Department of Immunology, Medical University of Warsaw, Warsaw, Poland
2Laboratory of Experimental Medicine, Medical University of Warsaw, Warsaw, Poland
3Department of Histology and Embryology, Medical University of Warsaw, Warsaw, Poland
4Laboratory of Experimental Medicine, Medical University of Warsaw, Warszawa, Poland
5Department of Laboratory Medicine, Medical University of Warsaw, Warsaw, Poland
6Medical University of Warsaw, Warsaw, Poland
7Department of Hematology, Transplantation, and Internal Diseases, Medical University of Warsaw, Warsaw, Poland

Min Dong1,2*, Angela Good, angela.good@cchmc.org1*, Alexander A. Vinks, PharmD, PhD, FCP1,2*, Russell E. Ware2,3 and Patrick T. McGann, MD, PhD4,5

1Division of Clinical Pharmacology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH
2Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH
3Division of Hematology, Children's Hospital Medical Center, Cincinnati, OH
4Department of Pediatrics, The Warren Alpert Medical School of Brown University, Providence, RI
5Lifespan Comprehensive Sickle Cell Center, Providence, RI

Ginette Balbin-Cuesta, MD, PhD1,2, Katherine Rybkin3*, Greggory Myers4* and Rami Khoriaty, MD4,5,6,7

1Medical Scientist Training Program, University of Michigan, Ann Arbor, MI
2Cellular and Molecular Biology Program, University of Michigan, Ann Arbor, MI
3College of Literature, Science, and the Arts, University of Michigan, Ann Arbor, MI
4Department of Cell and Developmental Biology, University of Michigan, Ann Arbor, MI
5Program in Cellular and Molecular Biology, University of Michigan, Ann Arbor, MI
6Rogel Cancer Center, University of Michigan, Ann Arbor, MI
7Department of Internal Medicine, Division of Hematology/Oncology, University of Michigan, Ann Arbor, MI

Jun Ho Jang, MD, PhD1, Raymond Wong, MBChB, MD2, Rodrigo Pavani, MD, PhD3*, Lisa Aurand, MD3, Bradley Dain, PhD3*, Lorah Perlee, PhD3*, Amal Souttou, MD3*, Jonathan Weyne, MD3* and Richard Kelly, BSc, MD4*

1Samsung Medical Center, Seoul, South Korea
2Sir YK Pao Centre for Cancer & Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong, Hong Kong
3Regeneron Pharmaceuticals, Inc., Tarrytown, NY
4Department of Haematology, St James University Hospital, Leeds, United Kingdom

Richard Kelly, BSc, MD1*, Nicola Houghton2*, Talha Munir, MBBS, MRCP, FRCPath, PhD3*, Petra Muus4*, Nora Youngs, BSc2*, Lisa Aurand, MD5, Bradley Dain, PhD5*, Rodrigo Pavani, MD, PhD5*, Lorah Perlee, PhD5*, Amal Souttou, MD5* and Morag Griffin, FRCPath, MRCP6*

1Department of Haematology, St James University Hospital, Leeds, United Kingdom
2St James’s University Hospital, Leeds, GBR
3Department of Haematology, St James’s University Hospital, Leeds, United Kingdom
4St James’s University Hospital, Leeds, United Kingdom
5Regeneron Pharmaceuticals, Inc., Tarrytown, NY
6St James's University Hospital, Sheffield, United Kingdom

Julien Maquet, MD, MSc1,2*, Margaux Lafaurie, PharmD, PhD2,3*, Marc Michel, MD4*, Maryse Lapeyre-Mestre, MD, PhD2,3* and Guillaume Moulis, MD, PhD2,5*

1Department of Internal Medicine, Toulouse University Hospital, Toulouse, France
2Clinical Investigation Center 1436, Toulouse University Hospital, Toulouse, France
3Department of Clinical Pharmacology, Toulouse University Hospital, Toulouse, France
4Henri-Mondor University Hospital, Assistance Publique-Hôpitaux de Paris, UPEC, Créteil, France
5Department of Internal medicine, Toulouse University Hospital, Toulouse, France

*signifies non-member of ASH